Clinical trials by condition

Amyloidosis clinical trials near you

49 studies for amyloidosis are recruiting volunteers at 333 research sites in 34 states.

Also called AL amyloidosis, ATTR amyloidosis.

Studies recruiting
49
Research sites
333
States
34

What is amyloidosis?

Amyloidosis is a group of conditions in which abnormal proteins, called amyloids, build up and form deposits in the body. The deposits can collect in organs such as the heart and kidneys, making them stiff and unable to work as they should.

There are three main kinds. Primary amyloidosis has no known cause. Secondary amyloidosis is caused by another disease, including some cancers. Familial amyloidosis is passed down through genes.

What a person notices depends on which organs are affected. Treatment depends on the kind: it aims to ease symptoms and limit the making of the abnormal proteins, and when another disease is the cause, that disease is treated too.

Written with AI from MedlinePlus, the National Library of Medicine's health information, and checked by our team on November 13, 2026. Read more on MedlinePlus

Areas with the most amyloidosis studies

Metro areas where studies for amyloidosis are recruiting, each study counted once in an area.

  1. 1BostonMassachusetts21 studies
  2. 2New YorkNew York17 studies
  3. 3RochesterMinnesota14 studies
  4. 4Los AngelesCalifornia12 studies
  5. 5DallasTexas10 studies
  6. 6PhiladelphiaPennsylvania8 studies
  7. 7DenverColorado7 studies
  8. 8HoustonTexas7 studies
  9. 9Kansas CityMissouri7 studies
  10. 10PortlandOregon7 studies

By state

Studies for amyloidosis recruiting in each state.

  • Massachusetts21 studies · 19 sites
  • Minnesota15 studies · 14 sites
  • New York15 studies · 28 sites
  • Texas13 studies · 27 sites
  • California12 studies · 23 sites
  • North Carolina11 studies · 19 sites
  • Florida10 studies · 21 sites
  • Tennessee9 studies · 10 sites
  • Maryland8 studies · 7 sites
  • Missouri8 studies · 12 sites
All 34 states

Whom the studies accept

The share of the amyloidosis studies open to each group. A study can accept several.

  • Adults 18 to 6496%
  • Adults 65 and over100%
  • Children and teens (under 18)4%
  • Healthy volunteers8%
  • Open to all sexes98%
  • Women only2%

Study phases

Earlier phases test safety in fewer people; later phases compare a treatment with the usual care in many.

  • Phase 18%
  • Phase 1/28%
  • Phase 214%
  • Phase 312%
  • Phase 44%
  • No phase (device, behavioral and other studies)12%
  • Not stated41%

Cite these figures

Free to use under CC BY 4.0. Please credit LocalTrial with a link to this page.

As text

Source: LocalTrial, Amyloidosis clinical trials near you, https://www.localtrial.com/clinical-trials/conditions/amyloidosis, updated November 13, 2026.

With the link, for a web page

Source: <a href="https://www.localtrial.com/clinical-trials/conditions/amyloidosis">LocalTrial, Amyloidosis clinical trials near you</a>, updated November 13, 2026.

About these figures

Counted from ClinicalTrials.gov, the U.S. registry of clinical studies, for studies recruiting in the United States that study amyloidosis. A study is counted once however many sites it has.

Updated November 13, 2026.

These figures describe studies, not advice. Talk to your doctor before joining one.

Tell us a little about yourself and we'll suggest the amyloidosis studies near you that may fit. Free and private.

Ready to see what's near you?

Find amyloidosis studies near me
Find amyloidosis studies near me